Neuroinflammation attenuation effects by celastrol and PDIA3 in the amygdala, hippocampus and dorsal raphe nucleus of obese mice

Chunyan Zhu; Xuemin Yao; Dandan Liu; Guoxin Zhang; Yongping Zhu; Hongyu Chi; Shuangpan Zhang; Jun Yang; Ying Liu; Jigang Wang; Na Lin

doi:10.1016/j.jpha.2023.10.002

Volume 14 Issue 2

Feb. 2024

Turn off MathJax

Article Contents

Article Navigation > Journal of Pharmaceutical Analysis > 2024 > 14(2): 287-290

Chunyan Zhu, Xuemin Yao, Dandan Liu, Guoxin Zhang, Yongping Zhu, Hongyu Chi, Shuangpan Zhang, Jun Yang, Ying Liu, Jigang Wang, Na Lin. Neuroinflammation attenuation effects by celastrol and PDIA3 in the amygdala, hippocampus and dorsal raphe nucleus of obese mice[J]. Journal of Pharmaceutical Analysis, 2024, 14(2): 287-290. doi: 10.1016/j.jpha.2023.10.002

Citation:

Chunyan Zhu, Xuemin Yao, Dandan Liu, Guoxin Zhang, Yongping Zhu, Hongyu Chi, Shuangpan Zhang, Jun Yang, Ying Liu, Jigang Wang, Na Lin. Neuroinflammation attenuation effects by celastrol and PDIA3 in the amygdala, hippocampus and dorsal raphe nucleus of obese mice[J]. Journal of Pharmaceutical Analysis, 2024, 14(2): 287-290. doi: 10.1016/j.jpha.2023.10.002

Citation:

Chunyan Zhu, Xuemin Yao, Dandan Liu, Guoxin Zhang, Yongping Zhu, Hongyu Chi, Shuangpan Zhang, Jun Yang, Ying Liu, Jigang Wang, Na Lin. Neuroinflammation attenuation effects by celastrol and PDIA3 in the amygdala, hippocampus and dorsal raphe nucleus of obese mice[J]. Journal of Pharmaceutical Analysis, 2024, 14(2): 287-290. doi: 10.1016/j.jpha.2023.10.002

PDF( 2174 KB)

Neuroinflammation attenuation effects by celastrol and PDIA3 in the amygdala, hippocampus and dorsal raphe nucleus of obese mice

doi: 10.1016/j.jpha.2023.10.002

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China

Funds:

This work was supported by the grants from the Natural Science Foundation of Beijing Municipality (Grant No.: 7212185), the Scientific and Technological Innovation project of China Academy of Chinese Medical Sciences (Grant No.: CI2021A03808), the National Natural Science Foundation of China (Grant Nos.: 82330124, 81974526, and 82274176), the Innovation Team and Talents Cultivation Program of the National Administration of Traditional Chinese Medicine, China (Program No.: ZYYCXTD-C-202002), the Special Project for Training Outstanding Young Scientific and Technological Talents (innovative type) of Necessary Scientific Research Business Expenses of China Academy of Chinese Medical Sciences (Project Nos.: ZZ13-YQ-051, and ZZ15-YQ-063), and the Fundamental Research Funds for the Central public welfare research institutes (Grant No.: ZXKT21010).

Received Date: Jun. 20, 2023
Accepted Date: Oct. 11, 2023
Rev Recd Date: Oct. 03, 2023
Publish Date: Feb. 29, 2024

Abstract

FullText(HTML)

References(5)

References

[1]	G.B.D.O. Collaborators, A. Afshin, M.H. Forouzanfar, et al. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med. 377 (2017) 13-27.
[2]	E. Pereira-Miranda, P.R.F. Costa, V.A.O. Queiroz, et al. Overweight and Obesity Associated with Higher Depression Prevalence in Adults: A Systematic Review and Meta-Analysis. J Am Coll Nutr. 36(2017) 223-233.
[3]	A.R. Atti, S. Valente, A. Iodice, et al. Metabolic Syndrome, Mild Cognitive Impairment, and Dementia: A Meta-Analysis of Longitudinal Studies. Am J Geriatr Psychiatry. 27(2019) 625-637.
[4]	J Liu, J Lee, MA Salazar Hernandez, et al., Treatment of obesity with celastrol, Cell., 161, 2015, 999–1011.
[5]	C.Y. Zhu C, J. Yang, Y.P. Zhu, et al. Celastrol alleviates comorbid obesity and depression by directly binding amygdala HnRNPA1 in a mouse model. Clin Transl Med. 11 (2021) e394.